{
  "ptid_time": "022_S_0066_2006-12-18",
  "img_path": "/data/qiuhui/data/adni/images/022_S_0066/2006-12-18/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 19,330 mm³, 49.8% below the reference mean. With a Z-score of -1.19 (11.6th percentile), this represents mild atrophy; hippocampal volume measures 6,398 mm³, 15.4% below the reference mean. With a Z-score of -1.50 (6.7th percentile), this represents mild atrophy; whole brain volume measures 810,072 mm³, 25.0% below the reference mean. With a Z-score of -3.24 (0.1th percentile), this represents profound atrophy; entorhinal cortex volume measures 2,858 mm³, 30.3% below the reference mean. With a Z-score of -2.05 (2.0th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,392 mm³, 28.9% below the reference mean. With a Z-score of -2.46 (0.7th percentile), this represents significant atrophy; middle temporal gyrus volume measures 14,994 mm³, 29.7% below the reference mean. With a Z-score of -2.67 (0.4th percentile), this represents significant atrophy. ",
  "text_data": "Age is 75.5 years. Gender is Male. Education: 18 years. MMSE: 30.0. Logical Memory: 17.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 1343.00 pg/mL (normal ); Total tau: 195.60 pg/mL (normal ); Phosphorylated tau: 16.71 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in multiple brain regions, including the hippocampus, entorhinal cortex, fusiform gyrus, and middle temporal gyrus, which are commonly affected in Alzheimer's disease. However, the normal CSF biomarkers (Aβ, T-tau, P-tau) and intact cognitive performance (MMSE 30) suggest that these structural changes have not yet translated into clinical impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (due to significant atrophy without cognitive decline)  \n**Confidence:** **Medium** (high confidence in structural abnormalities, but MCI diagnosis is provisional given normal biomarkers and cognition)  \n\n*Note: Given the discrepancy between imaging and biomarkers, alternative causes of atrophy (e.g., vascular, primary age-related tauopathy) should be considered.*",
  "timestamp": "2025-07-26T01:59:37.010805"
}